Pediarix® DTaP, Hepatitis B, and Polio Vaccine Indicated for People 6 Weeks Through 6 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorb

Features

• PEDIARIX® is indicated for active immunization against diphtheria
• tetanus
• pertussis
• infection caused by all known subtypes of hepatitis B virus
• and poliomyelitis Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid
• 10 Lf of tetanus toxoid
• 25 mcg of inactivated pertussis toxin (PT)
• 25 mcg of filamentous hemagglutinin (FHA)
• 8 mcg of pertactin (69 kiloDalton outer membrane protein)
• 10 mcg of HBsAg
• 40 D-antigen Units (DU) of Type 1 poliovirus (Mahoney)
• 8 DU of Type 2 poliovirus (MEF-1)
• and 32 DU of Type 3 poliovirus (Saukett) Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F) Prefilled Tip Lok® Syringe